☆ 4.5 Letter

Effect of prophylactic or pre-emptive use of tyrosine kinase inhibitors post-Allo SCT in bcr-abl positive acute lymphoblastic leukemia: a subanalysis of GITMO ph-positive ALL study

BONE MARROW TRANSPLANTATION (2022)

Related references

Note: Only part of the references are listed.

Article Biophysics

Second- and third-generation tyrosine kinase inhibitors for Philadelphia-positive adult acute lymphoblastic leukemia relapsing post allogeneic stem cell transplantation-a registry study on behalf of the EBMT Acute Leukemia Working Party

Klaus Hirschbuehl et al.

Summary: The study evaluated the efficacy of second- and third-generation TKI in 140 patients with Ph + ALL, showing a response rate of 71% and an overall survival rate of 49% at 2 years and 33% at 5 years. TKI were found to be important compounds for managing active Ph + ALL post alloSCT, with comparable toxicity to pretransplant use.

BONE MARROW TRANSPLANTATION (2021)

Add to Collection

Article Hematology

Impact of TKIs post-allogeneic hematopoietic cell transplantation in Philadelphia chromosome-positive ALL

Neeraj Saini et al.

BLOOD (2020)

Add to Collection

Article

Relapse Prevention with Tyrosine Kinase Inhibitors after Allogeneic Transplantation for Ph+ ALL, A Systematic Review

Zabih Warraich et al.

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2019)

Add to Collection

Article Hematology

Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia in the Era of Tyrosine Kinase Inhibitors: A Registry-Based Study of the Italian Blood and Marrow Transplantation Society (GITMO)

Anna Candoni et al.

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2019)

Add to Collection

Review Oncology

Use of Tyrosine Kinase Inhibitors to Prevent Relapse After Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Position Statement of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

Sebastian Gebel et al.

CANCER (2016)

Add to Collection

Article Hematology

Tyrosine kinase inhibitors improve long-term outcome of allogeneic hematopoietic stem cell transplantation for adult patients with Philadelphia chromosome positive acute lymphoblastic leukemia

Eolia Brissot et al.

HAEMATOLOGICA (2015)

Add to Collection

Article Oncology

Randomized comparison of prophylactic and minimal residual disease-triggered imatinib after allogeneic stem cell transplantation for BCR-ABL1-positive acute lymphoblastic leukemia

H. Pfeifer et al.

LEUKEMIA (2013)

Add to Collection

Article Hematology

Long-Term Follow-up of Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Impact of Tyrosine Kinase Inhibitors on Treatment Outcomes

Partow Kebriaei et al.

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2012)

Add to Collection

© Peeref 2019-2024. All rights reserved.